Lupus systémique et bélimumab : expérience du CHU Grenoble-Alpes
Alexis Bocquet(Centre Hospitalier Universitaire de Grenoble), Laurence Bouillet(University of California, Irvine), B. Colombe(Centre Hospitalier Universitaire de Grenoble), Anaïs Dartevel(Centre Hospitalier Universitaire de Grenoble), B. Millon(Centre Hospitalier Universitaire de Grenoble), M. Lugosi(Centre Hospitalier Universitaire de Grenoble), F. Sarrot-Reynauld(Centre Hospitalier Universitaire de Grenoble), A. Bosseray(Centre Hospitalier Universitaire de Grenoble), Alban Deroux(Centre Hospitalier Universitaire de Grenoble)
Cited by 0
Related Papers
The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria
|Allergy|2020|89
International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
|The Journal of Allergy and Clinical Immunology In Practice|2019|80
Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases
|Journal of the American Academy of Dermatology|2022|67